Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome
Ashima Gulati(All India Institute of Medical Sciences), Arvind Bagga(All India Institute of Medical Sciences), Jyoti Sharma(Bharati Vidyapeeth Deemed University), Mukta Mantan(Maulana Azad Medical College), Madhuri Kanitkar(Armed Forces Medical College), Indira Agarwal(Christian Medical College, Vellore), Pankaj Hari(Indian Council of Medical Research), Aditi Sinha, Vishnubhatla Sreenivas(All India Institute of Medical Sciences), Aarti Gupta(All India Institute of Medical Sciences), Amit Kumar Dinda(All India Institute of Medical Sciences)
Cited by 93
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|256
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome
|Clinical Journal of the American Society of Nephrology|2010|203
Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial
|American Journal of Kidney Diseases|2009|176